Ultra-late antibody-mediated rejection 30 years after a living-related renal allograft

American Journal of Transplantation

Volumn 5, Issue 10, 2005, Pages 2576-2581

  Weinstein, David ^a   Braun, William E ^a   Cook, Daniel ^a   McMahon, James T ^a   Myles, Jonathan ^a   Protiva, Deborah ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Antibody mediated rejection; C4d; Donor specific HLA antibody; Long term kidney transplant

Indexed keywords

AZATHIOPRINE; COMPLEMENT COMPONENT C4D; CREATININE; CYTOMEGALOVIRUS ANTIBODY; HLA ANTIBODY; HLA DQ8 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; ANTIBODY; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; DRUG DERIVATIVE; HLA ANTIGEN; MYCOPHENOLIC ACID; PEPTIDE FRAGMENT;

ADOLESCENT; ANTIBODY MEDIATED RENAL ALLOGRAFT REJECTION; ANTIBODY PRODUCTION; APHERESIS; ARTICLE; BLOOD GROUP TYPING; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG INFUSION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNE COMPLEX DEPOSITION; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY FUNCTION; PRIORITY JOURNAL; SYMPTOM; ALLOTRANSPLANTATION; BIOPSY; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; ELECTRON MICROSCOPY; FLUORESCENCE MICROSCOPY; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TEST; KIDNEY; KIDNEY TRANSPLANTATION; LIVING DONOR; LYMPHOCYTE; METABOLISM; METHODOLOGY; PHENOTYPE; TIME; TREATMENT OUTCOME;

ADOLESCENT; ANTIBODIES; ANTIBODY FORMATION; AZATHIOPRINE; BIOPSY; COMPLEMENT C4B; FEMALE; FLOW CYTOMETRY; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOGLOBULINS; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY; KIDNEY TRANSPLANTATION; LIVING DONORS; LYMPHOCYTES; METHYLPREDNISOLONE; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; MYCOPHENOLIC ACID; PEPTIDE FRAGMENTS; PHENOTYPE; PREDNISONE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33644672268     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01044.x     Document Type: Article

References (20)

1. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003 3 : 665 673.
2. Feucht HE. Complement C4d in graft capillaries - the missing link in the recognition of humoral alloreactivity. Am J Transplant 2003 3 : 646 652.
3. Racusen LC Colvin RB Solez K et al. Antibody-mediated rejection criteria - an addition to the Banff '97 classification of renal allograft rejection. Am J Transplant 2003 3 : 708 714.
4. Halloran PF. The clinical importance of alloantibody-mediated rejection. Am J Transplant 2003 3 : 639 640.
5. Braun WE. Laboratory and clinical management of the highly sensitized organ transplant recipient. Hum Immunol 1989 26 : 245 260.
6. Mauiyyedi S Pelle PD Saidman S et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001 12 : 574 582.
7. Mauiyyedi S Crespo M Collins AB et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002 13 : 779 787.
8. Montgomery RA Zachary AA Racusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000 70 : 887 895.
9. Regele H Bohmig GA Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002 13 : 2371 2380.
10. Bohmig GA Regele H Exner M et al. C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. J Am Soc Nephrol 2001 12 : 2482 2489.
11. Nickeleit V Zeiler M Gudat F Thiel G Mihatsch MJ. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002 13 : 242 251.
12. Halloran PF Schlaut J Solez K Srinivasa NS. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 1992 53 : 550 555.
13. Theruvath TP Saidman SL Mauiyyedi S et al. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation 2001 72 : 77 83.
14. Pei R Lee JH Shih NJ Chen M Terasaki PI. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003 75 : 43 49.
15. Muczynski KA Ekle DM Coder DM Anderson SK. Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: characterization, isolation, and regulation of MHC class II expression. J Am Soc Nephrol 2003 14 : 1336 1348.
16. Russell PS Chase CM Colvin RB. Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice. Transplantation 1997 64 : 1531 1536.
17. Braun WE. Long-term renal transplantation. Recent successes and new problems. Minerva Urol Nefrol 2003 55 : 13 24.
18. Mathew JM Joyce S Lawrence W Mohanakumar T. Evidence that antibodies eluted from rejected kidneys of HLA-identical transplants define a non-MHC alloantigen expressed on human kidneys. Transplantation 1991 52 : 559 562.
19. Sumitran-Holgersson S Wilczek HE Holgersson J Soderstrom K. Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation 2002 74 : 268 277.
20. Rentenaar RJ van Diepen FN Meijer RT et al. Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo. Kidney Int 2002 62 : 319 328.